Liver Cancer Therapeutics Market 2027 by Liver Cancer Type, Therapy | The Insight Partners

Liver Cancer Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Liver Cancer Type ( Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, Others ); Therapy ( Targeted Therapy, Immunotherapy, Radiation Therapy, Chemotherapy, Others )

Report Code: TIPRE00008971 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Liver cancer develops in the liver, also some cancers develop outside liver and some start spreading inside the organ. According to American Cancer Society, in 2019, an estimated 42,030 people were diagnosed with liver cancer in US. Liver cancer represents symptoms such as jaundice, abdominal pain, vomiting, back pain, nausea, and unexplained weight loss. Additionally, type-2 diabetes, family history, heavy alcoholism, and longtime exposure to alfatoxins are some of the risk factors which are responsible to cause liver cancer.

MARKET DYNAMICS

Increasing prevalence of liver cancer is expected to drive the market of liver cancer therapeutics during the forecast period. Additionally, increasing prevalence of risk factors such as diabetes and alcoholism will boost the prevalence of liver cancer, which will in turn drive the growth of the market by 2027.

MARKET SCOPE

The "Liver Cancer Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Liver Cancer Therapeutics Market with detailed market segmentation by liver cancer type, by therapy, and geography. The Liver Cancer Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Liver Cancer Therapeutics Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Liver Cancer Therapeutics Market is segmented on the basis by type and therapy type. Based on liver cancer type, the market is segmented into Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma, and others. Based on therapy, the market is segmented into targeted therapy, immunotherapy, radiation therapy, chemotherapy, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Liver Cancer Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Liver Cancer Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Liver Cancer Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Liver Cancer Therapeutics Market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Liver Cancer Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Liver Cancer Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Liver Cancer Therapeutics Market in the global market. Below mentioned is the list of few companies engaged in the Liver Cancer Therapeutics Market.

The report also includes the profiles of key Liver Cancer Therapeutics Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bristol-Myers Squibb
- Bayer AG
- Merck and Co., Inc.
- Koninklijke Philips N.V
- F. Hoffmann-La Roche Ltd
- Eisai Inc.
- ArQule Inc.
- Celsion Corp.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liver Cancer Therapeutics Market - By Liver Cancer Type
1.3.2 Liver Cancer Therapeutics Market - By Therapy
1.3.3 Liver Cancer Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVER CANCER THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVER CANCER THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LIVER CANCER THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVER CANCER THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. LIVER CANCER THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LIVER CANCER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - LIVER CANCER TYPE
7.1. OVERVIEW
7.2. LIVER CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEPATOCELLULAR CARCINOMA
7.3.1. Overview
7.3.2. Hepatocellular Carcinoma Market Forecast and Analysis
7.4. CHOLANGIO CARCINOMA
7.4.1. Overview
7.4.2. Cholangio Carcinoma Market Forecast and Analysis
7.5. HEPATOBLASTOMA
7.5.1. Overview
7.5.2. Hepatoblastoma Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. LIVER CANCER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. TARGETED THERAPY
8.3.1. Overview
8.3.2. Targeted Therapy Market Forecast and Analysis
8.4. IMMUNOTHERAPY
8.4.1. Overview
8.4.2. Immunotherapy Market Forecast and Analysis
8.5. RADIATION THERAPY
8.5.1. Overview
8.5.2. Radiation Therapy Market Forecast and Analysis
8.6. CHEMOTHERAPY
8.6.1. Overview
8.6.2. Chemotherapy Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. LIVER CANCER THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Liver Cancer Therapeutics Market Overview
9.1.2 North America Liver Cancer Therapeutics Market Forecasts and Analysis
9.1.3 North America Liver Cancer Therapeutics Market Forecasts and Analysis - By Liver Cancer Type
9.1.4 North America Liver Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.1.5 North America Liver Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Liver Cancer Therapeutics Market
9.1.5.1.1 United States Liver Cancer Therapeutics Market by Liver Cancer Type
9.1.5.1.2 United States Liver Cancer Therapeutics Market by Therapy
9.1.5.2 Canada Liver Cancer Therapeutics Market
9.1.5.2.1 Canada Liver Cancer Therapeutics Market by Liver Cancer Type
9.1.5.2.2 Canada Liver Cancer Therapeutics Market by Therapy
9.1.5.3 Mexico Liver Cancer Therapeutics Market
9.1.5.3.1 Mexico Liver Cancer Therapeutics Market by Liver Cancer Type
9.1.5.3.2 Mexico Liver Cancer Therapeutics Market by Therapy
9.2. EUROPE
9.2.1 Europe Liver Cancer Therapeutics Market Overview
9.2.2 Europe Liver Cancer Therapeutics Market Forecasts and Analysis
9.2.3 Europe Liver Cancer Therapeutics Market Forecasts and Analysis - By Liver Cancer Type
9.2.4 Europe Liver Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.2.5 Europe Liver Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Liver Cancer Therapeutics Market
9.2.5.1.1 Germany Liver Cancer Therapeutics Market by Liver Cancer Type
9.2.5.1.2 Germany Liver Cancer Therapeutics Market by Therapy
9.2.5.2 France Liver Cancer Therapeutics Market
9.2.5.2.1 France Liver Cancer Therapeutics Market by Liver Cancer Type
9.2.5.2.2 France Liver Cancer Therapeutics Market by Therapy
9.2.5.3 Italy Liver Cancer Therapeutics Market
9.2.5.3.1 Italy Liver Cancer Therapeutics Market by Liver Cancer Type
9.2.5.3.2 Italy Liver Cancer Therapeutics Market by Therapy
9.2.5.4 Spain Liver Cancer Therapeutics Market
9.2.5.4.1 Spain Liver Cancer Therapeutics Market by Liver Cancer Type
9.2.5.4.2 Spain Liver Cancer Therapeutics Market by Therapy
9.2.5.5 United Kingdom Liver Cancer Therapeutics Market
9.2.5.5.1 United Kingdom Liver Cancer Therapeutics Market by Liver Cancer Type
9.2.5.5.2 United Kingdom Liver Cancer Therapeutics Market by Therapy
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Liver Cancer Therapeutics Market Overview
9.3.2 Asia-Pacific Liver Cancer Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Liver Cancer Therapeutics Market Forecasts and Analysis - By Liver Cancer Type
9.3.4 Asia-Pacific Liver Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.3.5 Asia-Pacific Liver Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Liver Cancer Therapeutics Market
9.3.5.1.1 Australia Liver Cancer Therapeutics Market by Liver Cancer Type
9.3.5.1.2 Australia Liver Cancer Therapeutics Market by Therapy
9.3.5.2 China Liver Cancer Therapeutics Market
9.3.5.2.1 China Liver Cancer Therapeutics Market by Liver Cancer Type
9.3.5.2.2 China Liver Cancer Therapeutics Market by Therapy
9.3.5.3 India Liver Cancer Therapeutics Market
9.3.5.3.1 India Liver Cancer Therapeutics Market by Liver Cancer Type
9.3.5.3.2 India Liver Cancer Therapeutics Market by Therapy
9.3.5.4 Japan Liver Cancer Therapeutics Market
9.3.5.4.1 Japan Liver Cancer Therapeutics Market by Liver Cancer Type
9.3.5.4.2 Japan Liver Cancer Therapeutics Market by Therapy
9.3.5.5 South Korea Liver Cancer Therapeutics Market
9.3.5.5.1 South Korea Liver Cancer Therapeutics Market by Liver Cancer Type
9.3.5.5.2 South Korea Liver Cancer Therapeutics Market by Therapy
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Liver Cancer Therapeutics Market Overview
9.4.2 Middle East and Africa Liver Cancer Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Liver Cancer Therapeutics Market Forecasts and Analysis - By Liver Cancer Type
9.4.4 Middle East and Africa Liver Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.4.5 Middle East and Africa Liver Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Liver Cancer Therapeutics Market
9.4.5.1.1 South Africa Liver Cancer Therapeutics Market by Liver Cancer Type
9.4.5.1.2 South Africa Liver Cancer Therapeutics Market by Therapy
9.4.5.2 Saudi Arabia Liver Cancer Therapeutics Market
9.4.5.2.1 Saudi Arabia Liver Cancer Therapeutics Market by Liver Cancer Type
9.4.5.2.2 Saudi Arabia Liver Cancer Therapeutics Market by Therapy
9.4.5.3 U.A.E Liver Cancer Therapeutics Market
9.4.5.3.1 U.A.E Liver Cancer Therapeutics Market by Liver Cancer Type
9.4.5.3.2 U.A.E Liver Cancer Therapeutics Market by Therapy
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Liver Cancer Therapeutics Market Overview
9.5.2 South and Central America Liver Cancer Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Liver Cancer Therapeutics Market Forecasts and Analysis - By Liver Cancer Type
9.5.4 South and Central America Liver Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.5.5 South and Central America Liver Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Liver Cancer Therapeutics Market
9.5.5.1.1 Brazil Liver Cancer Therapeutics Market by Liver Cancer Type
9.5.5.1.2 Brazil Liver Cancer Therapeutics Market by Therapy
9.5.5.2 Argentina Liver Cancer Therapeutics Market
9.5.5.2.1 Argentina Liver Cancer Therapeutics Market by Liver Cancer Type
9.5.5.2.2 Argentina Liver Cancer Therapeutics Market by Therapy
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LIVER CANCER THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. BRISTOL-MYERS SQUIBB
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK AND CO., INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. KONINKLIJKE PHILIPS N.V
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN-LA ROCHE LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EISAI INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ARQULE INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CELSION CORP.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb
2. Bayer AG
3. Merck and Co., Inc.
4. Koninklijke Philips N.V
5. F. Hoffmann-La Roche Ltd
6. Eisai Inc.
7. ArQule Inc.
8. Celsion Corp.
TIPRE00008971
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking